Description
BLOOD, BLOOD PRODUCTS AND RELATED SERVICES - REMOVE EXCESS FUNDS FROM NTE TO
Base award description: BLOOD, BLOOD PRODUCTS AND RELATED SERVICES - TASK ORDER UNDER CONTRACT
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-10-01+$90,000= $90,000
- Mod 12010-12-02+$137,180= $227,180
- Mod P000022012-01-26-$3,899= $223,281
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-10-01 | +$90,000 | $90,000 | BLOOD, BLOOD PRODUCTS AND RELATED SERVICES - TASK ORDER UNDER CONTRACT |
| Mod 1· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2010-12-02 | +$137,180 | $227,180 | BLOOD, BLOOD PRODUCTS AND RELATED SERVICES - ORDER ADDITIONAL SERVICES AGAINST SAME TASK ORDER |
| Mod P00002· FUNDING ONLY ACTION | 2012-01-26 | −$3,899 | $223,281 | BLOOD, BLOOD PRODUCTS AND RELATED SERVICES - REMOVE EXCESS FUNDS FROM NTE TO |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PNAEF6YNHFY4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0127 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C25626N0210 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $239,128 | FY2026 |
| 36C25626N0209 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $71,646 | FY2026 |
| 36C24926N0133 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $390,791 | FY2026 |
| 36C25625N0105 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $144,871 | FY2025 |
| 36C24925N0158 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $162,074 | FY2025 |
Other recipients under Q301 from 502-ALEXANDRIA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613P0013 | CYTYC CORPORATION | 502-ALEXANDRIA | $5,280 | FY2013 |
| VA25612J1942 | BECKMAN COULTER, INC | 502-ALEXANDRIA | $19,133 | FY2012 |
| VA25612J1923 | POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 502-ALEXANDRIA | $16,154 | FY2012 |
| VA25612J1542 | TOSOH BIOSCIENCE, INC. | 502-ALEXANDRIA | $10,000 | FY2012 |
| VA25612J1541 | IRIS INTERNATIONAL, INC. | 502-ALEXANDRIA | $22,813 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA502C14023_3600_VA256P0761_3600 · retrieved 2026-09-26.